Ngā hua rapu - Key, Nigel

Analysis of Tissue Factor Positive Microparticles mā Key, Nigel S.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Current Treatment of Venous Thromboembolism mā Key, Nigel S., Kasthuri, Raj S.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Medical Management of Venous Thromboembolism: What the Interventional Radiologist Needs to Know mā Kasthuri, Raj S., Key, Nigel S.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

How I treat patients with inherited bleeding disorders who need anticoagulant therapy mā Martin, Karlyn, Key, Nigel S.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Sickle-Cell Trait: Novel Clinical Significance mā Key, Nigel S., Derebail, Vimal K.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Microparticle Analysis in Disorders of Hemostasis and Thrombosis mā Mooberry, Micah J., Key, Nigel S.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Pregnancy in Sickle Trait: What we Know and What we Don’t mā Wilson, Samuel, Ellsworth, Patrick, Key, Nigel S.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Negative Health Implications Of Sickle Cell Trait in High Income Countries: From The Football Field To The Laboratory mā Key, Nigel S., Connes, Philippe, Derebail, Vimal K.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Coagulation Abnormalities of Sickle Cell Disease: Relationship with Clinical Outcomes and the Effect of Disease Modifying Therapies mā Noubouossie, Denis, Key, Nigel S., Ataga, Kenneth I.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis mā Gordeuk, Victor R., Key, Nigel S., Prchal, Josef T.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

4084 Predictors of mortality among non-severe hemophilia A patients in the United States mā Lim, Ming Y, Cheng, Dunlei, Key, Nigel

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Tissue Factor; from Morawitz to Microparticles mā Key, Nigel S., Geng, Jian-Guo, Bach, Ronald R

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Red blood cells and thrombin generation in sickle cell disease mā Whelihan, Matthew F., Lim, Ming Y., Key, Nigel S.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Prolonged Remission of Cancer of Unknown Primary following Initiation of Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria mā Lim, Ming Y., Volmar, Keith E., Key, Nigel S.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues mā Campello, Elena, Ilich, Anton, Simioni, Paolo, Key, Nigel S.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

How to discuss gene therapy for haemophilia? A patient and physician perspective mā Miesbach, Wolfgang, O’Mahony, Brian, Key, Nigel S., Makris, Mike

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Using heparin molecules to manage COVID‐2019 mā Liu, Jian, Li, Jine, Arnold, Katelyn, Pawlinski, Rafal, Key, Nigel S.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Effect of chemotherapy and longitudinal analysis of circulating extracellular vesicle tissue factor activity in patients with pancreatic and colorectal cancer mā Kasthuri, Raj S., Hisada, Yohei, Ilich, Anton, Key, Nigel S., Mackman, Nigel

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses mā Mackman, Nigel, Antoniak, Silvio, Wolberg, Alisa S., Kasthuri, Raj, Key, Nigel S.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Neutrophils: back in the thrombosis spotlight mā Noubouossie, Denis F., Reeves, Brandi N., Strahl, Brian D., Key, Nigel S.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa